Study2020Open access

Heat shock protein 90 modulates cutaneous vasodilation during an exercise-heat stress, but not during passive whole-body heating in young women

McGarr GW, Fujii N, Schmidt MD, Muia CM, Kenny GP

Physiological reports · 8 citations

How it was studied

Design
Controlled clinical trial (classified by our AI screen)
Studied in
People
Main outcome
Health markers and function

Who paid for it

Funding
Independent funding
University or hospital
University of Ottawa
Government
Natural Sciences and Engineering Research Council of Canada
Grants
Natural Sciences and Engineering Research Council of Canada (RGPIN 2020); Natural Sciences and Engineering Research Council of Canada (rgpin-2020-03891); Natural Sciences and Engineering Research Council of Canada (03891)

Based on 2 listed funder(s) and full-text disclosure statement.

Publication

Published
2020-08-01 · Physiol Rep · vol. 8 · issue 16 · p. e14552
Publisher
Wiley
Cited
10 citations · more than 61% of similar papers · 0.5× the field average
References
37 works
Access
Open access (journal) · CC-BY
Research areas
Thermoregulation and physiological responses · Exercise and Physiological Responses · Infrared Thermography in Medicine
Keywords
Geldanamycin, Medicine, Vasodilation, Thermoregulation, Nitric oxide synthase, Heat shock protein, Internal medicine, Endocrinology, Hsp90, Chemistry, Nitric oxide, Biochemistry
MeSH
microcirculation, skin, humans, lactams, macrocyclic, benzoquinones, ng-nitroarginine methyl ester, enzyme inhibitors, exercise, vasodilation, adult, female, hsp90 heat-shock proteins, nitric oxide synthase, hot temperature

5 authors

From CA, JP

  • Gregory W. McGarrUniversity of Ottawa
  • Naoto FujiiUniversity of Tsukuba; University of Ottawa
  • Madison D. SchmidtUniversity of Ottawa
  • Caroline M. MuiaUniversity of Ottawa
  • Glen Patrick Kenny · correspondingUniversity of Ottawa

Abstract

Heat shock protein 90 (HSP90) modulates exercise-induced cutaneous vasodilation in young men via nitric oxide synthase (NOS), but only when core temperature is elevated ~1.0°C. While less is known about modulation of this heat loss response in women during exercise, sex differences may exist. Further, the mechanisms regulating cutaneous vasodilation can differ between exercise- and passive-heat stress. Therefore, in 11 young women (23 ± 3 years), we evaluated whether HSP90 contributes to NOS-dependent cutaneous vasodilation during exercise (Protocol 1) and passive heating (Protocol 2) and directly compared responses between end-exercise and a matched core temperature elevation during passive heating. Cutaneous vascular conductance (CVC%max ) was measured at four forearm skin sites continuously treated with (a) lactated Ringers solution (control), (b) 178 μM Geldanamycin (HSP90 inhibitor), (c) 10 mM L-NAME (NOS inhibitor), or (d) combined 178 μM Geldanamycin and 10 mM L-NAME. Participants completed both protocols during the early follicular (low hormone) phase of the menstrual cycle (0-7 days). Protocol 1: participants rested in the heat (35°C) for 70 min and then performed 50 min of moderate-intensity cycling (~55% VO2peak ) followed by 30 min of recovery. Protocol 2: participants were passively heated to increase rectal temperature by 1.0°C, comparable to end-exercise. HSP90 inhibition attenuated CVC%max relative to control at end-exercise (p %max relative to control for both protocols (all p < .05), they did not differ from each other. We show that HSP90 modulates cutaneous vasodilation NOS-dependently during exercise in young women, with no effect during passive heating, despite a similar NOS contribution.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.